Large Grant: “Neural Correlates of Impulsivity and their Modulation by Dopamine in Problem/Pathological Gambling”

Principal Investigator: Andrew Kayser, MD, PhD, University of California, San Francisco
Awarded $172,500 in 2013

Aim: Evaluate a novel translational (and potentially therapeutic) approach for gambling disorder: inhibitors of the dopamine-degrading enzyme catechol-O-methyltransferase (COMT). Several COMT-inhibitor drugs are already FDA-approved, and can be readily tested in human subjects.

Year: 2013
Type: Project Grants